Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Spinal Muscular Atrophy: Opportunity Assessment and Forecast - Update" report has been added to ResearchAndMarkets.com's offering. The SMA market across ...

DelveInsight’s, “Spinal Muscular Atrophy Pipeline Insight 2024” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Spinal muscular atrophy pipeline landscape. It ...

Emmes today announced that Casimir’s research on the development of the Duchenne Video Assessment (DVA) scorecards was published in PLOS ONE. Emmes acquired Casimir in March 2022, and the group is now ...

"Duchenne Muscular Dystrophy Pipeline Analysis"DelveInsight's, "Duchenne Muscular Dystrophy - Pipeline Insight, 2025,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs ...